Literature DB >> 26138227

Semiparametric transformation models for multiple continuous biomarkers in ROC analysis.

Eunhee Kim1, Donglin Zeng2, Xiao-Hua Zhou3.   

Abstract

Recent technological advances continue to provide noninvasive and more accurate biomarkers for evaluating disease status. One standard tool for assessing the accuracy of diagnostic tests is the receiver operating characteristic (ROC) curve. Few statistical methods exist to accommodate multiple continuous-scale biomarkers in the framework of ROC analysis. In this paper, we propose a method to integrate continuous-scale biomarkers to optimize classification accuracy. Specifically, we develop semiparametric transformation models for multiple biomarkers. We assume that unknown and marker-specific transformations of biomarkers follow a multivariate normal distribution. Our models accommodate biomarkers subject to limits of detection and account for the dependence among biomarkers by including a subject-specific random effect. We also propose a diagnostic measure using an optimal linear combination of the transformed biomarkers. Our diagnostic rule does not depend on any monotone transformation of biomarkers and is not sensitive to extreme biomarker values. Nonparametric maximum likelihood estimation (NPMLE) is used for inference. We show that the parameter estimators are asymptotically normal and efficient. We illustrate our semiparametric approach using data from the Endometriosis, Natural History, Diagnosis, and Outcomes (ENDO) study.
© 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Biomarkers; Nonparametric maximum likelihood estimation; ROC analysis; Semiparametric efficiency; Transformation models

Mesh:

Substances:

Year:  2015        PMID: 26138227     DOI: 10.1002/bimj.201400043

Source DB:  PubMed          Journal:  Biom J        ISSN: 0323-3847            Impact factor:   2.207


  1 in total

1.  A semiparametric method for comparing the discriminatory ability of biomarkers subject to limit of detection.

Authors:  Lixuan Yin; Guoqing Diao; Aiyi Liu
Journal:  Stat Med       Date:  2017-07-25       Impact factor: 2.373

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.